TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
183,762
|
189,863
|
177,608 |
| Financial expenses |
3,402
|
7,713
|
5,411 |
| Earnings before taxes |
38,766
|
31,663
|
30,242 |
| EBITDA |
42,315
|
33,546
|
31,928 |
| Total assets |
251,336
|
211,222
|
186,954 |
| Current assets |
181,844
|
149,004
|
116,267 |
| Current liabilities |
43,247
|
38,839
|
39,249 |
| Equity capital |
183,248
|
157,434
|
130,086 |
| - share capital |
190
|
197
|
196 |
| Employees (average) |
121
|
122
|
120 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
72.9%
|
74.5%
|
69.6% |
| Turnover per employee |
1,519
|
1,556
|
1,480 |
| Profit as a percentage of turnover |
21.1%
|
16.7%
|
17.0% |
| Return on assets (ROA) |
16.8%
|
18.6%
|
19.1% |
| Current ratio |
420.5%
|
383.6%
|
296.2% |
| Return on equity (ROE) |
21.2%
|
20.1%
|
23.2% |
| Change turnover |
179
|
11,340
|
29,332 |
| Change turnover % |
0%
|
6%
|
20% |
| Chg. No. of employees |
-1
|
2
|
-3 |
| Chg. No. of employees % |
-1%
|
2%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.